Modified measles vaccine schedule to help prevent allergies in babies
Part of Immune system & allergy, Infections, Lungs & breathing, Skin clinical trials.
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 6 months old at the time of joining
- You can sign a consent form and agree to follow the study steps
- Your child is generally healthy with no serious ongoing health problems
- Your child is fully vaccinated for age under the Swiss schedule
- At least 2 doses of DTP-containing vaccine have been given, and the last dose was at least 2 weeks ago
- Your child has no reasons they should not receive MMR (measles vaccine)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether giving babies a shot called nirsevimab (which helps protect against RSV, a common virus that can cause breathing problems) early in life can reduce wheezing later on. It compares babies who got the shot with those who didn't.
This study tests a combined one-shot vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6 who've already had their first shots. It aims to see if this new combination vaccine is as effective and safe as giving separate boosters.
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
This study checks if giving measles-rubella and yellow fever vaccines together on the same day is safe and works well for babies. It is for healthy infants aged 9-12 months who have not had these vaccines before. The goal is to see if giving both at once is a good option for protecting babies.
This study looks at how the immune system responds to measles infection or vaccination in adults. It may help explain why some people develop stronger immunity than others.
This study looks at how children's immune systems respond to measles, comparing those who are protected to those who are not. It may help us understand why measles affects children differently, which could lead to better care.
Hear when a new Respiratory Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.